IMS Health sets Tuesday roadshow for €275 million eight-year notes

By Paul A. Harris

Portland, Ore., March 16 – IMS Health Inc. is planning a roadshow set to take place on Tuesday in London for its €275 million offering of eight-year senior notes (expected ratings B3/B+), according to a market source.

The deal is set to price thereafter.

Goldman Sachs International, BofA Merrill Lynch, Barclays, HSBC, JPMorgan and Wells Fargo are the joint bookrunners for the Rule 144A and Regulation S offering.

Deutsche Bank, Fifth Third, Morgan Stanley, Mizuho, RBC, SunTrust Robinson Humphrey Inc. and TPG Capital are the co-managers.

The Danbury, Conn.-based provider of information and technology services to the health care industry plans to use the proceeds to partially fund the acquisition of certain customer relationship management and strategic data businesses of Cegedim SA.

The notes become callable after three years at par plus 75% of the coupon. A special call provision makes the entire issue callable at the reoffer price if the acquisition has not closed or terminated prior to Sept. 1, 2015.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.